| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-08 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-07 |